Arterial homeostasis, inflammation, and erythropoietic growth factors

Pascal Goldschmidt-Clermont, Anna Mae Diehl

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A neurohumoral link between kidneys and the heart has been established, particularly in the context of hypertension and cardiomyopathy. Beyond this neuro-endocrine pathway, another connecting system theoretically recruits growth factors that are selectively produced by the kidneys and have the ability to promote a distant reaction at the level of bone marrow. This reaction differentiates and circulates vascular progenitor cells capable of repairing the injured cardiovascular system. Reducing injuries (prevention) stabilizes disease processes by reducing tissue damage and destruction but the gradual degradation of the body's natural repair mechanisms eventually allows progressive reactivation of disease processes. In this light, a focus on tissue repair rather than injury prevention may hold the key to controlling chronic heart diseases. This article examines the medical therapies, including recombinant human erythropoietin, that have been shown to improve the function and survival of endothelial progenitor cells and promote the healing of damaged tissue.

Original languageEnglish
JournalReviews in Cardiovascular Medicine
Volume6
Issue numberSUPPL. 3
StatePublished - Dec 14 2005
Externally publishedYes

Fingerprint

Arteritis
Intercellular Signaling Peptides and Proteins
Homeostasis
Kidney
Wounds and Injuries
Erythropoietin
Cardiovascular System
Cardiomyopathies
Blood Vessels
Heart Diseases
Chronic Disease
Stem Cells
Bone Marrow
Hypertension
Therapeutics

Keywords

  • Endothelial progenitor cells
  • Erythropoietin
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Arterial homeostasis, inflammation, and erythropoietic growth factors. / Goldschmidt-Clermont, Pascal; Diehl, Anna Mae.

In: Reviews in Cardiovascular Medicine, Vol. 6, No. SUPPL. 3, 14.12.2005.

Research output: Contribution to journalArticle

Goldschmidt-Clermont, P & Diehl, AM 2005, 'Arterial homeostasis, inflammation, and erythropoietic growth factors', Reviews in Cardiovascular Medicine, vol. 6, no. SUPPL. 3.
Goldschmidt-Clermont, Pascal ; Diehl, Anna Mae. / Arterial homeostasis, inflammation, and erythropoietic growth factors. In: Reviews in Cardiovascular Medicine. 2005 ; Vol. 6, No. SUPPL. 3.
@article{9751577f5feb423ea26d4d87bd1cca3c,
title = "Arterial homeostasis, inflammation, and erythropoietic growth factors",
abstract = "A neurohumoral link between kidneys and the heart has been established, particularly in the context of hypertension and cardiomyopathy. Beyond this neuro-endocrine pathway, another connecting system theoretically recruits growth factors that are selectively produced by the kidneys and have the ability to promote a distant reaction at the level of bone marrow. This reaction differentiates and circulates vascular progenitor cells capable of repairing the injured cardiovascular system. Reducing injuries (prevention) stabilizes disease processes by reducing tissue damage and destruction but the gradual degradation of the body's natural repair mechanisms eventually allows progressive reactivation of disease processes. In this light, a focus on tissue repair rather than injury prevention may hold the key to controlling chronic heart diseases. This article examines the medical therapies, including recombinant human erythropoietin, that have been shown to improve the function and survival of endothelial progenitor cells and promote the healing of damaged tissue.",
keywords = "Endothelial progenitor cells, Erythropoietin, Vascular endothelial growth factor",
author = "Pascal Goldschmidt-Clermont and Diehl, {Anna Mae}",
year = "2005",
month = "12",
day = "14",
language = "English",
volume = "6",
journal = "Reviews in Cardiovascular Medicine",
issn = "1530-6550",
publisher = "MedReviews LLC",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Arterial homeostasis, inflammation, and erythropoietic growth factors

AU - Goldschmidt-Clermont, Pascal

AU - Diehl, Anna Mae

PY - 2005/12/14

Y1 - 2005/12/14

N2 - A neurohumoral link between kidneys and the heart has been established, particularly in the context of hypertension and cardiomyopathy. Beyond this neuro-endocrine pathway, another connecting system theoretically recruits growth factors that are selectively produced by the kidneys and have the ability to promote a distant reaction at the level of bone marrow. This reaction differentiates and circulates vascular progenitor cells capable of repairing the injured cardiovascular system. Reducing injuries (prevention) stabilizes disease processes by reducing tissue damage and destruction but the gradual degradation of the body's natural repair mechanisms eventually allows progressive reactivation of disease processes. In this light, a focus on tissue repair rather than injury prevention may hold the key to controlling chronic heart diseases. This article examines the medical therapies, including recombinant human erythropoietin, that have been shown to improve the function and survival of endothelial progenitor cells and promote the healing of damaged tissue.

AB - A neurohumoral link between kidneys and the heart has been established, particularly in the context of hypertension and cardiomyopathy. Beyond this neuro-endocrine pathway, another connecting system theoretically recruits growth factors that are selectively produced by the kidneys and have the ability to promote a distant reaction at the level of bone marrow. This reaction differentiates and circulates vascular progenitor cells capable of repairing the injured cardiovascular system. Reducing injuries (prevention) stabilizes disease processes by reducing tissue damage and destruction but the gradual degradation of the body's natural repair mechanisms eventually allows progressive reactivation of disease processes. In this light, a focus on tissue repair rather than injury prevention may hold the key to controlling chronic heart diseases. This article examines the medical therapies, including recombinant human erythropoietin, that have been shown to improve the function and survival of endothelial progenitor cells and promote the healing of damaged tissue.

KW - Endothelial progenitor cells

KW - Erythropoietin

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=28644441734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28644441734&partnerID=8YFLogxK

M3 - Article

C2 - 16340935

AN - SCOPUS:28644441734

VL - 6

JO - Reviews in Cardiovascular Medicine

JF - Reviews in Cardiovascular Medicine

SN - 1530-6550

IS - SUPPL. 3

ER -